CD69 and metabolic dysfunction-associated steatotic liver disease: The clinical benefits of these short-term changes require further exploration; however, long-term dietary restriction in patients with non-alcoholic fatty liver disease resulted in a decrease in intrahepatic MAIT CD69 expression and improvements in inflammatory-mediated hepatic steatosis [47].